117 related articles for article (PubMed ID: 36888995)
1. ALS-Linked A315T and A315E Mutations Enhance β-Barrel Formation of the TDP-43
Liu X; Li X; Qiao Q; Li F; Wei G
ACS Chem Neurosci; 2023 Apr; 14(7):1310-1320. PubMed ID: 36888995
[TBL] [Abstract][Full Text] [Related]
2. ALS-associated A315E and A315pT variants exhibit distinct mechanisms in inducing irreversible aggregation of TDP-43
Liu X; Lao Z; Li X; Dong X; Wei G
Phys Chem Chem Phys; 2022 Jul; 24(26):16263-16273. PubMed ID: 35758309
[TBL] [Abstract][Full Text] [Related]
3. Atomistic Insights into A315E Mutation-Enhanced Pathogenicity of TDP-43 Core Fibrils.
Li F; Chen Y; Liu X; Tang Y; Dong X; Wei G
ACS Chem Neurosci; 2022 Sep; 13(18):2743-2754. PubMed ID: 36053560
[TBL] [Abstract][Full Text] [Related]
4. Characterization of β-domains in C-terminal fragments of TDP-43 by scanning tunneling microscopy.
Xu M; Zhu L; Liu J; Yang Y; Wu JY; Wang C
J Struct Biol; 2013 Jan; 181(1):11-6. PubMed ID: 23138004
[TBL] [Abstract][Full Text] [Related]
5. Characterizing TDP-43
Laos V; Do TD; Bishop D; Jin Y; Marsh NM; Quon B; Fetters M; Cantrell KL; Buratto SK; Bowers MT
ACS Chem Neurosci; 2019 Sep; 10(9):4112-4123. PubMed ID: 31430111
[TBL] [Abstract][Full Text] [Related]
6. Dissecting the Effect of ALS Mutation G335D on the Early Aggregation of the TDP-43 Amyloidogenic Core Peptide: Helix-to-β-Sheet Transition and Conformational Shift.
Li F; Chen Y; Tang Y; Liu X; Wei G
J Chem Inf Model; 2023 Jun; 63(11):3579-3590. PubMed ID: 37218694
[TBL] [Abstract][Full Text] [Related]
7. ALS-Causing Mutations Significantly Perturb the Self-Assembly and Interaction with Nucleic Acid of the Intrinsically Disordered Prion-Like Domain of TDP-43.
Lim L; Wei Y; Lu Y; Song J
PLoS Biol; 2016 Jan; 14(1):e1002338. PubMed ID: 26735904
[TBL] [Abstract][Full Text] [Related]
8. Activation of ER Stress and Autophagy Induced by TDP-43 A315T as Pathogenic Mechanism and the Corresponding Histological Changes in Skin as Potential Biomarker for ALS with the Mutation.
Wang X; Zhou S; Ding X; Ma M; Zhang J; Zhou Y; Wu E; Teng J
Int J Biol Sci; 2015; 11(10):1140-9. PubMed ID: 26327808
[TBL] [Abstract][Full Text] [Related]
9. Dissecting the effect of ALS mutation S375G on the conformational properties and aggregation dynamics of TDP-43
Xu Z; Zhang J; Tang J; Gong Y; Zou Y; Zhang Q
Biophys Chem; 2024 Jul; 310():107230. PubMed ID: 38615537
[TBL] [Abstract][Full Text] [Related]
10. Amyotrophic lateral sclerosis mutant TDP-43 may cause synaptic dysfunction through altered dendritic spine function.
Jiang T; Handley E; Brizuela M; Dawkins E; Lewis KEA; Clark RM; Dickson TC; Blizzard CA
Dis Model Mech; 2019 May; 12(5):. PubMed ID: 31036551
[TBL] [Abstract][Full Text] [Related]
11. Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS.
Ke YD; van Hummel A; Stevens CH; Gladbach A; Ippati S; Bi M; Lee WS; Krüger S; van der Hoven J; Volkerling A; Bongers A; Halliday G; Haass NK; Kiernan M; Delerue F; Ittner LM
Acta Neuropathol; 2015 Nov; 130(5):661-78. PubMed ID: 26437864
[TBL] [Abstract][Full Text] [Related]
12. Dissecting how ALS-associated D290V mutation enhances pathogenic aggregation of hnRNPA2
Tan Y; Chen Y; Liu X; Tang Y; Lao Z; Wei G
Int J Biol Macromol; 2023 Jun; 241():124659. PubMed ID: 37119915
[TBL] [Abstract][Full Text] [Related]
13. Wild-type and A315T mutant TDP-43 exert differential neurotoxicity in a Drosophila model of ALS.
Estes PS; Boehringer A; Zwick R; Tang JE; Grigsby B; Zarnescu DC
Hum Mol Genet; 2011 Jun; 20(12):2308-21. PubMed ID: 21441568
[TBL] [Abstract][Full Text] [Related]
14. Zn
Preethi S; Bharathi V; Patel BK
Int J Biol Macromol; 2021 Apr; 176():186-200. PubMed ID: 33577819
[TBL] [Abstract][Full Text] [Related]
15. Influence of ALS-linked M337V mutation on the conformational ensembles of TDP-43
Zeng J; Tang Y; Dong X; Li F; Wei G
Proteins; 2023 Feb; ():. PubMed ID: 36841957
[TBL] [Abstract][Full Text] [Related]
16. Mutant TDP-43 does not impair mitochondrial bioenergetics in vitro and in vivo.
Kawamata H; Peixoto P; Konrad C; Palomo G; Bredvik K; Gerges M; Valsecchi F; Petrucelli L; Ravits JM; Starkov A; Manfredi G
Mol Neurodegener; 2017 May; 12(1):37. PubMed ID: 28482850
[TBL] [Abstract][Full Text] [Related]
17. Computational insights into mechanism of AIM4-mediated inhibition of aggregation of TDP-43 protein implicated in ALS and evidence for in vitro inhibition of liquid-liquid phase separation (LLPS) of TDP-43
Girdhar A; Bharathi V; Tiwari VR; Abhishek S; Deeksha W; Mahawar US; Raju G; Singh SK; Prabusankar G; Rajakumara E; Patel BK
Int J Biol Macromol; 2020 Mar; 147():117-130. PubMed ID: 31917988
[TBL] [Abstract][Full Text] [Related]
18. ALS-linked mutations enlarge TDP-43-enriched neuronal RNA granules in the dendritic arbor.
Liu-Yesucevitz L; Lin AY; Ebata A; Boon JY; Reid W; Xu YF; Kobrin K; Murphy GJ; Petrucelli L; Wolozin B
J Neurosci; 2014 Mar; 34(12):4167-74. PubMed ID: 24647938
[TBL] [Abstract][Full Text] [Related]
19. Non-invasive characterization of amyotrophic lateral sclerosis in a hTDP-43
Weerasekera A; Crabbé M; Tomé SO; Gsell W; Sima D; Casteels C; Dresselaers T; Deroose C; Van Huffel S; Rudolf Thal D; Van Damme P; Himmelreich U
Neuroimage Clin; 2020; 27():102327. PubMed ID: 32653817
[TBL] [Abstract][Full Text] [Related]
20. Prevention of intestinal obstruction reveals progressive neurodegeneration in mutant TDP-43 (A315T) mice.
Herdewyn S; Cirillo C; Van Den Bosch L; Robberecht W; Vanden Berghe P; Van Damme P
Mol Neurodegener; 2014 Jun; 9():24. PubMed ID: 24938805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
